BCTX
BRIACELL THERAP (BCTX)
NASDAQ
$3.36+$0.05 (+1.51%)
Price as of Jun 03, 2026 7:53 PM EDT
  • $26.4M
    Market Cap
  • -90.41%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
07/31/2025
07/31/2024
07/31/2023
07/31/2022
Income Statement
Total Operating Revenue
56,473
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
892,005
+66.77%
534,861
+3.38%
517,398
N/A
N/A
N/A
Gross Profit
-835,532
+56.21%
-534,861
+3.38%
-517,398
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-21.3M
-21.74%
-27.2M
+77.21%
-15.3M
+91.19%
-8.0M
+509.77%
Depreciation and Amortization Expense
91,356
+33.12%
68,626
+349.39%
15,271
-0.007%
15,272
N/A
Total Operating Expenses
27.2M
-18.38%
33.3M
+320.01%
7.9M
+9.19%
7.3M
+96.96%
Operating Profit
-27.2M
-18.38%
-33.3M
+43.22%
-23.3M
+52.22%
-15.3M
+119.24%
Interest Income
119,958
-58.35%
288,018
-67.68%
891,213
+551.80%
136,731
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-979
-97.88%
Interest Income and Expense and Net
119,958
-58.35%
288,018
-67.68%
891,213
+556.50%
135,752
+394.50%
Total Nonoperating Income and Expense
114,511
-56.39%
262,566
-91.16%
3.0M
+303,257.51%
979
-97.88%
Income before Taxes
-27.2M
-18.38%
-33.3M
+43.22%
-23.3M
+52.22%
-15.3M
+3,469.40%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-26.3M
+449.14%
-4.8M
-76.40%
-20.3M
-24.35%
-26.8M
+6,165.88%
Net Income from Continuing Operations Applicable to Common
-26.3M
+449.14%
-4.8M
-76.40%
-20.3M
-24.35%
-26.8M
+6,165.88%
Basic EPS and Net Income
-62.19
+21,344.83%
-0.29
-77.69%
-1.30
-24.86%
-1.73
N/A
Diluted EPS and Net Income
-62.19
+21,344.83%
-0.29
-77.69%
-1.30
-24.86%
-1.73
N/A
Basic Weighted Average Shares
423,114
-97.43%
16.5M
+5.35%
15.6M
+0.81%
15.5M
N/A
Diluted Weighted Average Shares
423,114
-97.43%
16.5M
+5.35%
15.6M
+0.81%
15.5M
N/A
Balance Sheet
Cash and Cash Equivalents
10.5M
+1,117.25%
862,089
-95.94%
21.3M
-48.22%
41.0M
-28.33%
Short-Term Investments
7.4M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
17.9M
+1,972.44%
862,089
-95.94%
21.3M
-48.22%
41.0M
-28.33%
Total Current Assets
19.9M
+445.36%
3.7M
-86.44%
26.9M
-36.36%
42.3M
-26.73%
Accumulated Depreciation
159,982
+133.12%
68,626
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
296,819
-23.53%
388,175
+15,427.00%
2,500
0.00%
2,500
N/A
Total Long-Term Assets
1.7M
-22.33%
2.2M
+931.48%
215,070
-6.63%
230,341
N/A
Total Assets
21.6M
+268.68%
5.9M
-78.38%
27.2M
-36.20%
42.6M
-26.65%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.0M
-46.68%
7.5M
+314.17%
1.8M
+91.42%
941,087
+69.02%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
337,672
-69.19%
1.1M
-96.24%
29.1M
-6.92%
31.3M
+13,786.83%
Total Liabilities
4.0M
-46.68%
7.5M
+314.17%
1.8M
+91.42%
941,087
N/A
Retained Earnings
-111.8M
+30.79%
-85.4M
+5.94%
-80.7M
+33.64%
-60.3M
+283.08%
Total Stockholders Equity
17.3M
+745.60%
-2.7M
-28.92%
-3.8M
-136.57%
10.3M
-81.96%
Total Shares Outstanding
1.9M
-89.70%
18.3M
+14.41%
16.0M
+2.99%
15.5M
+1.63%
Cash Flow
Cash from Operating Activities
-28.2M
+16.76%
-24.1M
+1.61%
-23.7M
+90.20%
-12.5M
+61.14%
Capital Expenditures
N/A
N/A
456,801
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-7.6M
+1,021.44%
-681,801
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
45.4M
+928.49%
4.4M
+11.75%
4.0M
+205.65%
-3.7M
-105.76%
Financials Ratio
Gross Margin
-1,479.52%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-48,173.11%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-191.21%
+559.16%
-29.01%
-50.18%
-58.22%
+9.14%
-53.35%
N/A
Return on Equity
-359.23%
-342.24%
148.29%
+123.93%
-619.75%
+680.39%
-79.42%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.01
+922.91%
0.49
-96.73%
14.96
-66.76%
45.00
N/A
Cash Ratio
2.64
+2,183.98%
0.12
-99.02%
11.80
-72.95%
43.61
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow